Prot #SRK-015-003 (SAPPHIRE): Phase 3, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Apitegromab (SRK-015) in Patients with Later-Onset Spinal Muscular Atrophy Receiving Background Nusinersen or Risdiplam Therapy

Project: Research project

Project Details

StatusActive
Effective start/end date1/31/23 → 1/31/26

Funding

  • Ann & Robert H. Lurie Children's Hospital of Chicago (Prot #SRK-015-003)
  • Scholar Rock, Inc. (Prot #SRK-015-003)